462
T.T. Kung et al
Adrenal involvement in the activity of rolipram
References
CHAPMAN, R.W., SEHRING, S.J., GARLISI, C.G., FALCONE, A.,
KUNG, T.T., STELTS, D., MINNICOZZI, M., JONES, H., UMLAND,
S., EGAN, R.W. & KREUTNER, W. (1998). Anti-in¯ammatory
activity of inhaled mometasone furoate in allergic mice.
Arzneim.-Forsch. Drug Res., 48, 384 ± 391.
KAMBAYASHI, T., JACOB, C.O., ZHOU, D., MAZUREK, N., FONG, M.
& STRASSMANN, G. (1995). Cyclic nucleotide phosphodiesterase
type IV participates in the regulation of IL-10 and in the
subsequent inhibition of TNF-a and IL-6 release by endotoxin-
stimulated macrophages. J. Immunol., 155, 4909 ± 4916.
KAY, A.B. (1991). Asthma and in¯ammation. J. Allergy Clin.
Immunol., 87, 893 ± 910.
CHENG, J.B., WATSON, J.W., PAZOLES, C.J., ESKRA, J.D., GRIF-
FITHS, R.J., COHAN, V.L., TURNER, C.R., SHOWELL, H.J.
&
PETTIPHER, E.R. (1997). The phosphodiesterase type 4 (PDE4)
inhibitor CP-80, 633 elevates plasma cyclic AMP levels and
decreases tumor necrosis factor-a (TNF-a) production in mice:
eect of adrenalectomy. J. Pharmacol. Exp. Ther., 280, 621 ± 626.
CROCKER, C., TOWNLEY, R.G. & KHAN, M.M. (1996). Phospho-
diesterase inhibitors suppress proliferation of peripheral blood
mononuclear cells and interleukin-4 and-5 secretion by human T-
helper type 2 cells. Immunopharmacology, 31, 223 ± 225.
DANAHAY, H. & BROADLEY, K.J. (1997). Eect of inhibitors of
phosphodiesterase, on antigen-induced bronchial hyperreactivity
in conscious sensitized guinea pigs and airway leukocyte
in®ltration. Br. J. Pharmacol., 120, 289 ± 297.
KUMARI, M., COVER, P.O., POYSER, R.H. & BUCKINGHAM, J.C.
(1997). Stimulation of the hypothalamo-pituitary-adrenal axis in
the rat by three selective type-4 phosphodiesterase inhibitors: in
vitro and in vivo studies. Br. J. Pharmacol., 121, 459 ± 468.
KUNG, T.T., JONES, H., ADAMS III G.K., UMLAND, S.P., KREUT-
NER, W., EGAN, R.W., CHAPMAN, R.W. & WATNICK, A.S. (1994).
Characterization of murine model of allergic pulmonary
in¯ammation. Int. Arch. Allergy Immunol., 105, 83 ± 90.
LILLY, C.M., CHAPMAN, R.W., SEHRING, S.J., MAUSER, P., EGAN,
R.W. & DRAZEN, J.M. (1996). Eects of interleukin 5-induced
pulmonary eosinophilia on airway reactivity in the guinea pig.
Am. J. Physiol., 270, L368 ± L375.
DEBIE, T.T., HESSEL, E.M., VAN ARK, I., VAN ESCH, B., HOFMAN,
G., NIJKAMP, F.P. & VAN OOSTERHOUT, A.J.M. (1996). Eect of
dexamethasone and endogenous corticosterone on airway
hyperresponsiveness and eosinophilia in the mouse. Br. J.
Pharmacol., 119, 1484 ± 1490.
MAUSER, P.J., PITMAN, A., WITT, A., FERNANDEZ, X., ZURCHER,
J., KUNG, T., JONES, H., WATNICK, A.S., EGAN, R.W., KREUT-
NER, W. & ADAMS III G.K. (1993). Inhibitory eect of the TRFK-
5 anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev.
Respir. Dis., 148, 1623 ± 1627.
DENT, G., GIEMBYCZ, M.A., EVANS, P.M., RABE, K.F. & BARNES,
P.J. (1994). Suppression of human eosinophil respiratory burst
and cyclic AMP hydrolysis by inhibitors of type IV phospho-
diesterase: interaction with the b-adrenoceptor agonist albuterol.
J. Pharmacol. Exp. Ther., 271, 1167 ± 1174.
PALFREYMAN, M.N. & SOUNESS, J.E. (1996). Phosphodiesterase
type IV inhibitors. In Progress in Medicinal Chemistry. ed. Ellis,
G.P. & Luscombe, D.K., Vol. 33, pp. 1 ± 52. Amsterdam: Elsevier
Science BV.
PETTIPHER, E.R., ESKRA, J.D. & LABASI, J.M. (1997). The inhibitory
eect of rolipram on TNF-a production in mouse blood ex vivo is
dependent upon the release of corticosterone and adrenaline.
Cytokine, 9, 582 ± 586.
PETTIPHER, E.R., LABASI, J.M., SALTER, E.D., STAM, E.J., CHENG,
J.B. & GRIFFITHS, R.J. (1996). Regulation of tumor necrosis
factor production by adrenal hormones in vivo: insights into the
anti-in¯ammatory activity of rolipram. Br. J. Pharmacol., 117,
15430 ± 1534.
ELENKOV, I.J., HASKO, G., KOVACS, K.J.
& VIZI, E.S. (1995).
Modulation of lipopolysaccharide-induced tumor necrosis fac-
tor-a production by selective a-and b adrenergic drugs in mice. J.
Neuroimmunol., 61, 123 ± 131.
GOZZARD, N., EL-HASHIM, A., HERD, C.M., BLAKE, S.M., HOL-
BROOK, M., HUGHES, B-., HIGGS, G.A. & PAGE, C.P. (1996).
Eect of the glucocorticosteroid budesonide and
a novel
phosphodiesterase type 4 inhibitor CDP840 on antigen-induced
airway responses in neonatally immunized rabbits. Br. J.
Pharmacol., 118, 1201 ± 1208.
RAEBURN, D.
& KARLSSON, J.A. (1993). Eects of isoenzyme-
selective inhibitors of cyclic nucleotide phosphodiesterase on
microvascular leak in guinea pig airways in vivo. J. Pharmacol.
Exp. Ther., 267, 1147 ± 1152.
GRISWOLD, D.E., WEBB, E.F., BRETON, J., WHITE, J.R., MARSHALL,
P.L. & TORPHY, T.J. (1993). Eect of selective phosphodiesterase
type IV inhibitor, rolipram, on ¯uid and cellular phase of
in¯ammatory response. In¯ammation, 17, 333 ± 344.
HADLEY, A.J., KUMARI, M., COVER, P.O., OSBORNE, J., POYSER, R.,
FLACK, J.D. & BUCKINGHAM, J.C. (1996). Stimulation of the
hypothalamo-pituitary-adrenal axis in the rat by the type 4
phosphodiesterase (PDE-4) inhibitor, denbufylline. Br. J.
Pharmacol., 119, 463 ± 470.
HESSEL, E.M., VAN OOSTERHOUT, A.J.M., HOFSTRA, C.L., DE BIE,
J.J., GARSSEN, J., VAN LOVEREN, H., VERHEYEN, A.K.C.P.,
SAVELKOUL, H.F.J. & NIJKAMP, F.P. (1995). Bronchoconstric-
tion and airway hyperresponsiveness after ovalbumin inhalation
in sensitized mice. Eur. J. Pharmacol., 294, 401 ± 412.
HIGBEE, M.D., KUMAR, M. & GALANT, S.P. (1982). Stimulation of
endogenous catecholamine release by theophylline: a proposed
additional mechanism of action for theophylline eects. J.
Allergy Clin. Immunol., 70, 377 ± 382.
HOLBROOK, M., GOZZARD, N., JAMES, T., HIIGGS, G. & HUGHES,
B. (1996). Inhibition of bronchospasm and ozone-induced airway
hyperresponsiveness in the guinea pig by CDP840, a novel
phosphodiesterase type 4 inhibitor. Br. J. Pharmacol., 118,
1192 ± 1200.
HOWELL, R.E., JENKINS, L.P. & HOWELL, D.E. (1995). Inhibition of
lipopolysaccharide-induced pulmonary edema by isozyme-selec-
tive phosphodiesterase inhibitors in guinea pigs. J. Pharmacol.
Exp. Ther., 275, 703 ± 709.
HUGHES, B., HOWAT, D., LISLE, H., HOLBROOK, M., JAMES, T.,
GOZZARD, N., BLEASE, K., HUGHES, P., KINGABY, R., WAR-
RELLOW, G., ALEXANDER, R., HEAD, J., BOYD, E., EATON, M.,
PERRY, M., WALES, M., SMITH, B., OWENS, R., CATTERALL, C.,
LUMB, S., RUSSELL, A., ALLEN, R., MERRIMAN, M., BLOXHAM,
SATO, J., HORI, S. & KAWAMURA, M. (1998). Eect of theophylline,
caeine and dimethylxanthines on endogenous glucocorticoid
levels in mice. A possible mechanism of anti-in¯ammatory
activity of theophylline. Pharm. Pharmacol. Commun., 4, 499 ±
501.
SCHUESSLER, T.F. & BATES, J.H.T. (1995). A computer-controlled
research ventilator for small animals: design and evaluation.
IEEE Trans. Biomed. Eng., 42, 860 ± 866.
TORPHY, T.J. (1998). Phosphodiesterase isozymes. Molecular targets
for novel antiasthma agents. Am. J. Respir. Crit. Care Med., 157,
351 ± 370.
TOURNOY, K.G., KIPS, J.C., SCHOU, C. & PAUWELS, R.A. (2000).
Airway eosinophilia is nor a requirement for allergen-induced
airway hyperresponsiveness. Clin. Exp. Allergy., 30, 79 ± 85.
TURNER, C.R., ANDRESEN, C.J., SMITH, W.B. & WATSON, J.W.
(1994). Eects of rolipram on responses to acute and chronic
antigen exposure in monkeys. Am. J. Respir. Crit. Care Med.,
149, 1153 ± 1159.
UNDEM, B.J., MEEKER, S.N.
& CHEN, J. (1994). Inhibition of
neurally mediated nonadrenergic, noncholinergic contractions of
guinea pig bronchus by isozyme-selective phosphodiesterase
inhibitors. J. Pharmacol. Exp. Ther., 271, 811 ± 817.
UNDERWOOD, D.C., BOCHNOLOICZ, S., OSBORN, R.R., KOTZER,
C.J., LUTTMANN, M.A., HAY, D.W.P., GORYCKI, P.D., CHRIS-
TENSEN, S.B. & TORPHY, T.J. (1998). Antiasthmatic activity of
the second-generation phosphodiesterase 4 (PDE 4) inhibitor SB
207499 (Air¯o) in the guinea pig. J. Pharmacol. Exp. Ther., 287,
988 ± 995.
UNDERWOOD, D.C., KOTZER, C.J., BOCHNOWICZ, S., OSBORN,
R.R., LUTTMAN, M.A., HAY, D.W.P. & TORPHY, T.J. (1994).
Comparison of phosphodiesterase III, IV and dual III/IV
inhibitors on bronchospasm and pulmonary eosinophil in¯ux in
guinea pigs. J. Pharmacol. Exp. Ther., 270, 250 ± 259.
M.
eosinophilia and bronchoconstriction by CDP840,
&
HIGGS, G. (1996). The inhibition of antigen-induced
novel
a
stereo-selective inhibitor of phosphodiesterase type-4. Br. J.
Pharmacol., 118, 1183 ± 1191.
British Journal of Pharmacology, vol 130 (2)